Michael J. Running Sells 646 Shares of Plexus Corp. (NASDAQ:PLXS) Stock

Plexus Corp. (NASDAQ:PLXS - Get Free Report) insider Michael J. Running sold 646 shares of the stock in a transaction that occurred on Friday, May 30th. The shares were sold at an average price of $130.05, for a total transaction of $84,012.30. Following the sale, the insider now directly owns 630 shares of the company's stock, valued at $81,931.50. The trade was a 50.63% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website.

Plexus Stock Performance

Shares of NASDAQ:PLXS traded up $0.31 during midday trading on Thursday, reaching $132.19. The company's stock had a trading volume of 31,942 shares, compared to its average volume of 168,273. The firm has a market capitalization of $3.58 billion, a PE ratio of 30.67 and a beta of 0.80. Plexus Corp. has a twelve month low of $100.96 and a twelve month high of $172.89. The stock has a fifty day moving average of $125.94 and a 200 day moving average of $140.88. The company has a quick ratio of 0.70, a current ratio of 1.53 and a debt-to-equity ratio of 0.07.

Plexus (NASDAQ:PLXS - Get Free Report) last released its quarterly earnings data on Wednesday, April 23rd. The technology company reported $1.66 earnings per share for the quarter, topping analysts' consensus estimates of $1.54 by $0.12. The firm had revenue of $980.17 million for the quarter, compared to analyst estimates of $980.07 million. Plexus had a net margin of 3.03% and a return on equity of 10.36%. The business's quarterly revenue was up 1.4% compared to the same quarter last year. During the same quarter in the prior year, the business earned $0.94 earnings per share. On average, equities analysts expect that Plexus Corp. will post 5.9 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

A number of research firms have issued reports on PLXS. Benchmark reaffirmed a "buy" rating and issued a $160.00 price target on shares of Plexus in a report on Wednesday. Needham & Company LLC reaffirmed a "buy" rating and issued a $162.00 price target (down previously from $172.00) on shares of Plexus in a report on Friday, April 25th. Finally, Stifel Nicolaus set a $145.00 price target on shares of Plexus in a report on Thursday, April 24th. Two research analysts have rated the stock with a hold rating and three have given a buy rating to the stock. Based on data from MarketBeat, Plexus currently has an average rating of "Moderate Buy" and a consensus price target of $155.67.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently added to or reduced their stakes in the company. TD Private Client Wealth LLC acquired a new stake in shares of Plexus in the 4th quarter worth $28,000. Aquatic Capital Management LLC lifted its stake in shares of Plexus by 134.0% in the 4th quarter. Aquatic Capital Management LLC now owns 234 shares of the technology company's stock worth $37,000 after acquiring an additional 134 shares during the period. R Squared Ltd acquired a new stake in shares of Plexus in the 4th quarter worth $45,000. Nomura Asset Management Co. Ltd. increased its holdings in shares of Plexus by 45.5% in the 4th quarter. Nomura Asset Management Co. Ltd. now owns 320 shares of the technology company's stock valued at $50,000 after purchasing an additional 100 shares in the last quarter. Finally, Versant Capital Management Inc increased its holdings in shares of Plexus by 1,000.0% in the 1st quarter. Versant Capital Management Inc now owns 473 shares of the technology company's stock valued at $61,000 after purchasing an additional 430 shares in the last quarter. Institutional investors and hedge funds own 94.45% of the company's stock.

Plexus Company Profile

Plexus Corp. provides electronic manufacturing services in the United States and internationally. It offers design, develop, supply chain, new product introduction, and manufacturing solutions, as well as sustaining services to companies in the healthcare/life sciences, industrial/commercial, aerospace/defense, and communications market sectors.